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We examined the influence on the interferon (IFN) signaling pathway of infection with herpes simplex virus type 1 (HSV-1)
strain VR3. Data from reporter gene assays showed that expression of both type I and type II IFN-inducible genes was
dramatically suppressed during the early stage of HSV-1 infection (2 to 3 h postinfection). During these periods, phosphor-
ylation levels of janus kinases (JAKs) and STATs did not increase after treatment of HSV-1-infected FL cells with IFN-a or
IFN-g, although cellular protein levels of the JAKs and the STATs were not significantly changed. In contrast, the inhibitory
effect of HSV-1 on phosphorylation of STAT1 was not observed in U937 cells, which show resistance to steady-state
accumulation of RNA for HSV-1 immediate-early genes. The phosphorylation of STAT1 in FL cells was not inhibited by
infection with a UV-inactivated virus. These results indicate that viral gene expression or viral protein production is necessary
for the inhibition of phosphorylation by HSV-1. © 2001 Academic PressKey Words: herpes simplex virus type 1; interferon; JAK/STAT pathway; STAT1; STAT2; Jak1; Jak2; Tyk2; tyrosine
phosphorylation.
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Interferon (IFN) plays an important role in the defense
of a cell against viral infection. It works through the
induction or activation of antiviral enzymes such as the
29,59-oligoadenyl synthetase/RNase L system, the dou-
ble-stranded RNA-activated protein kinase (PKR), and the
MxA protein (Fujii, 1994; Kerr and Stark, 1992; Samuel,
1991; Sen and Ransohoff, 1993). The intracellular signal
transduction pathway of IFN is known to be the JAK/STAT
pathway (Darnell et al., 1994; Goodbourn et al., 2000;
Stark et al., 1998). The binding of IFNs to their specific
receptors stimulates the phosphorylation, and therefore
the activation, of janus kinases (JAKs), which in turn
activate STAT1 and/or STAT2 through phosphorylation.
IFN-a induces the transcription factor ISGF3, which con-
sists of three components: phosphorylated STAT1, phos-
phorylated STAT2, and p48 (also called IRF-9 or ISGF3g).
imilarly, IFN-g induces the transcription factor GAF, a
omodimer of phosphorylated STAT1a. The induced
SGF3 complex specifically binds to the ISRE (interferon-
timulated response element), and the GAF complex
pecifically binds to the GAS (g activation sequence).
oth ISRE and GAS are located in the promoter region of
he IFN-inducible genes and promote the genes’ expres-
ion.
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119Viruses, including both DNA and RNA viruses, can
nhibit such IFN-induced host defense mechanisms by
arious strategies. Many viruses are known to suppress
FN-induced antiviral activity by inhibiting the JAK/STAT
ignaling pathway (Alcami and Koszinowski, 2000; Good-
ourn et al., 2000), which is considered to be an impor-
ant strategy for escaping the host defense system. A
eview of recent reports indicated that the mechanisms
f inhibition are varied (Alcami and Koszinowski, 2000;
oodbourn et al., 2000). Some viruses reduce the con-
stitutive or basal levels of particular molecules that con-
tribute to the JAK/STAT pathway; for example, human
cytomegalovirus (HCMV) reduces the basal levels of
Jak1 and p48, although the mechanism by which it does
this is unknown (Miller et al., 1998, 1999), and simian
irus 5 and mumps virus degrade STAT1 (Didcock et al.,
999; Fujii et al., 1999; Yokosawa et al., 1998). Inactivation
f components of the JAK/STAT pathway by particular
iral products has also been demonstrated following
nfection by several types of virus. For example, T antigen
f murine polyoma virus and E7 protein of human papil-
omavirus 16 bind to Jak1 and p48, respectively (Barnard
nd McMillan, 1999; Weihua et al., 1998). Recent studies
ndicate that the human herpes simplex virus type 1
HSV-1) activates IFN-inducible genes in the absence of
e novo cellular protein synthesis (Mossman et al., 2001;
icholl et al., 2000). This response is indicated to be
uppressed by HSV-1 infection when viral genes are
xpressed (Mossman et al., 2001). The evidence sug-
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120 YOKOTA ET AL.gested that HSV-1 has a mechanism for suppression of
the IFN signaling pathway. Here we report a novel mech-
anism for the suppression of the IFN signaling pathway
during an early stage of infection by HSV-1.
RESULTS
Suppression of IFN-inducible gene expression during
an early stage of HSV-1 infection
We examined the effect of HSV-1 infection on IFN-
inducible gene expression by a reporter gene assay
using luciferase as the reporter. To examine the re-
sponse to IFN-a, five tandem repeats of ISRE were used
as an enhancer element of the firefly luciferase gene. We
used a dual luciferase assay system using the Renilla
luciferase gene controlled under the HSV thymidine ki-
nase promoter as a control, in order to determine the
specific changes of the reporter activity by IFN and
HSV-1 treatment and to correct the transfection efficacy
of the plasmid DNA. Treatment with 1000 IU/ml IFN-a for
4 h increased firefly luciferase activity about 10-fold,
compared with the untreated control. Although HSV-1
infection itself did not alter firefly luciferase activity at 6 h
postinfection (p.i.), the induction of the firefly luciferase
activity by IFN-a treatment was dramatically suppressed
by infection with HSV-1 at a multiplicity of infection of 5
(m.o.i. 5) 2 h prior to the IFN-a treatment (Fig. 1A). To
examine IFN-g-induced gene expression, four tandem
repeats of the GAS element were used as an enhancer
FIG. 1. Effect of HSV-1 infection on induction of IFN-inducible genes
determined by a reporter gene assay. FL cells were transfected with
reporter plasmids containing luciferase reporter genes linked to IFN-
responsive enhancers, pIRSE-Luc for IFN-a stimulation (A) or pGAS-
uc for IFN-g stimulation (B), plus pRL-TK as an internal reference of
transfection efficacy. The transiently expressed transfectants were in-
fected with HSV-1 at m.o.i. 5 or left uninfected as control. After 2 h
incubation, 1000 IU/ml IFN-a or IFN-g was added, and then the cells
were incubated for another 4 h. The cells were lysed, and the luciferase
activities in the resulting cell lysates were measured. All experiments
were carried out in triplicate. The results are expressed as fold induc-
tion, which is relative to the values obtained from control experiments
with neither HSV-1 infection nor IFN treatment.element for the firefly luciferase gene. Similar to what
was seen for IFN-a, IFN-g treatment enhanced the fireflyuciferase activity about 5-fold compared to the untreated
ontrol, and the enhancement was strongly suppressed
y HSV-1 infection 2 h prior to the IFN-g treatment (Fig.
1B). The results indicate that HSV-1 suppresses the sig-
nal transduction of both type I IFN (IFN-a/b) and type II
FN (IFN-g), and therefore the subsequent IFN-induced
gene expression, during an early stage of infection.
Protein levels of STATs, p48, and janus kinases during
HSV-1 infection
To determine the suppression mechanism of IFN-in-
ducible gene expression by HSV-1 infection, first, we
investigated changes of protein levels of STAT1, STAT2,
p48, Jak1, Jak2, and Tyk2 in FL cells during HSV-1 VR3
infection by Western blotting (Fig. 2). At late stage of
infection (16 h p.i.), protein levels of STAT2 and Jak1 were
dramatically decreased. On the other hand, STAT1a and
b, p48, Jak2, and Tyk2 did not show significant changes
even at 16 h p.i. The results indicate that the protein
levels of all molecules tested did not show any signifi-
cant changes during early stage of infection when the
suppression of IFN-inducible gene expression was seen
as shown in Fig. 1.
Inhibition of IFN-induced phosphorylation of STAT1a
and STAT2 by HSV-1 infection
Protein levels of molecules contributing IFN signaling
pathway did not change during the early infection stage
as shown above (Fig. 2), so we analyzed the activation
step, namely phosphorylation, of the signal transduction
molecules. First IFN-induced tyrosine (Tyr) 701 phos-
phorylation of STAT1a in HSV-1-infected cells was ana-
FIG. 2. Changes of protein levels of STAT1, STAT2, p48, Jak1, Tyk2,
and Jak2 in FL cells by HSV-1 infection. FL cells were infected with the
HSV-1 strain VR3 at m.o.i. 5. At various periods, the cells were lysed,
and the lysates (30 mg per lane) were applied to SDS–PAGE [on a 6%
(w/v) acrylamide gel, except for p48 and actin on a 12.5% (w/v) gel] and
analyzed by Western blotting. Actin was determined as a control for
protein loading.
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121SUPPRESSION OF IFN SIGNALING BY HSV-1lyzed by Western blotting. Both IFN-a- and IFN-g-induced
hosphorylation of STAT1a was significantly inhibited 3 h
p.i. of FL cells with HSV-1 (Figs. 3A and 4B). However,
protein levels of STAT1 did not show a significant change
during these periods. Similar results for the inhibition of
STAT2 phosphorylation, which was determined by immu-
noprecipitation with anti-STAT2 antibody followed by
Western blotting using anti-phosphotyrosine antibody,
were observed in HSV-1-infected FL cells after treatment
with IFN-a (Fig. 3B).
To investigate whether the suppression of STAT phos-
FIG. 3. Inhibition of IFN-a-induced tyrosine phosphorylation of
TAT1a and STAT2 by HSV-1 infection in FL cells. (A) FL cells were
infected with the HSV-1 strain VR3 for various times at m.o.i. 5. At each
period, the cells were treated with IFN-a (1000 IU/ml) for 10 or 20 min
nd then lysed. The lysate (30 mg per lane) was applied to SDS–PAGE
n a 6% (w/v) polyacrylamide gel and analyzed by Western blotting
sing anti-Tyr-phosphorylated STAT1 and anti-STAT1 antibodies. (B) FL
ells were infected with HSV-1 VR3 for 6 h at m.o.i. 5. The infected cells
nd uninfected control cells were treated with IFN-a (1000 IU/ml) for 10
or 20 min and then lysed. STAT2 proteins were precipitated from the
lysate with anti-STAT2 antibody and then analyzed by Western blotting
using anti-phosphotyrosine (pY) antibody and anti-STAT2 antibody.
FIG. 4. Effect on IFN-induced STAT1 phosphorylation by UV-inacti-
ated HSV-1 infection in FL cells. FL cells were infected with native or
V-inactivated HSV-1 VR3 for 6 h at m.o.i. 5 and then treated with 1000
U/ml IFN-a (A) or IFN-g (B) for 10 or 20 min. The resulting cell lysate
d
t
was analyzed by Western blotting using anti-Tyr-phosphorylated STAT1
and anti-STAT1 antibodies as shown in Fig. 3.horylation is dependent on the expression of HSV-1
enes, FL cells were infected with UV-inactivated HSV-1.
o production of virus particles and no cytopathic effects
f the UV-inactivated virus were found in FL cells or in
ero cells as an indicator (data not shown). No inhibition
f STAT1a phosphorylation was found in FL cells in-
fected with the UV-inactivated HSV-1 after treatment with
either IFN-a or IFN-g (Figs. 4A and 4B). Furthermore, the
inhibition of IFN-a-induced STAT1a phosphorylation was
not observed in the human monocytic cell U937 after
infection of HSV-1 for 6 h at m.o.i. 5 (Fig. 5). It has been
reported that U937 cells have a mechanism that protects
them against HSV-1 at the step of viral replication, but not
at the infection or penetration steps. In U937 cells, viral
DNA is transported to the cell nucleus, but steady-state
accumulation of viral RNA for immediate-early (IE) genes
does not occur (Stewart et al., 1992; Tenney and Mora-
han, 1987, 1991). These results indicate that HSV-1 inhib-
its the phosphorylation, and therefore the activation, of
STAT1a and STAT2 in a manner that is dependent on viral
ene expression or viral protein production.
To confirm the specificity of the inhibitory effect on
TAT phosphorylation, other protein phosphorylation
as examined. Heat-shock-induced phosphorylation of
eat shock factor 1, which is a transcription factor for
tress-responsible genes such as heat shock protein
enes (Wu, 1995), was not altered by HSV-1 infection
ntil at least 6 h p.i. (data not shown). Double-stranded
NA [poly(rI) z poly(rC)]-induced hyperphosphorylation
n several C-terminal serine and threonine residues of
nterferon-regulatory factor 3, which is a component of
he transcriptional activating complex for IFN-b produc-
tion (Lin et al., 1998; Weaver et al., 1998), was not sup-
pressed by HSV-1 infection until at least 6 h p.i. (data not
shown).
Inhibition of IFN-induced phosphorylation of JAKs by
HSV-1 infection
Since STAT1a and STAT2 are directly phosphorylated
y IFN-activated JAKs, we suspected that the suppres-
ion of STAT phosphorylation might be caused by the
FIG. 5. Effect on IFN-induced STAT1 phosphorylation by HSV-1 in-
fection in U937 cells. U937 cells were infected with HSV-1 for 6 h at
m.o.i. 5 and then treated with IFN-a (1000 IU/ml) for 10 or 20 min. The
resulting cell lysate was analyzed by Western blotting using anti-Tyr-
phosphorylated STAT1 and anti-STAT1 antibodies as shown in Fig. 3.ownregulation of JAK activity. We therefore examined
he effect of HSV-1 infection on the phosphorylation, and
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122 YOKOTA ET AL.therefore the activation, of JAKs by IFN estimated by
immunoprecipitation with respective JAK-specific anti-
body followed by Western blotting with anti-phosphoty-
rosine antibody. Jak1 and Tyk2 phosphorylation induced
by IFN-a was downregulated 3 h after HSV-1 infection
Fig. 6A). Similarly, IFN-g-induced phosphorylation of
ak1 and Jak2 was also downregulated after HSV-1 in-
ection for 3 h (Fig. 6B). However, cellular protein levels of
hese JAKs, which were estimated by Western blotting of
he whole-cell extracts (Fig. 2) and the immunoprecipi-
ates by using the respective JAK-specific antibody (Fig.
), were not altered under these conditions of HSV-1
nfection and IFN treatment. We conclude that impaired
hosphorylation of JAKs results in the suppression of
TAT phosphorylation.
DISCUSSION
In this study, we show that HSV-1 inhibits the IFN
ignaling pathway by the suppression of IFN-induced
hosphorylation of STATs and JAKs early in the process
f infection (2 to 3 h p.i.). Since STATs are directly phos-
horylated by JAKs (Darnell et al., 1994; Stark et al., 1998),
the inhibition of STAT phosphorylation is thought to be
due to a failure of JAK activation. Indeed, the phosphor-
ylation of JAKs was poor in FL cells infected with HSV-1.
The inhibition of phosphorylation seems to require the
expression of HSV-1 genes and the subsequent produc-
FIG. 6. Downregulation of IFN-a-induced Jak1 and Tyk2 phosphory-
lation (A) and IFN-g-induced Jak1 and Jak2 phosphorylation (B) by
SV-1 infection. FL cells were infected with HSV-1 VR3 for 6 h at m.o.i.
, and then treated with IFN-a (1000 IU/ml) or IFN-g (1000 IU/ml) for 10
or 20 min. The kinase proteins were immunoprecipitated from the cell
lysate with specific antibodies and analyzed by SDS–PAGE on a 6%
polyacrylamide gel and followed by Western blotting using anti-phos-
photyrosine (pY) antibody and anti-Jak1, anti-Tyk2, or anti-Jak2 antibody.tion of viral proteins, although the expression of the
HSV-1 genes did not affect the protein levels of the JAK
s
oand STAT molecules in the periods of HSV-1 infection
used during this experiment. This evidence is the first
report of suppression of JAK phosphorylation by a DNA
virus. HSV-1 seemed to have a broad inhibitory function,
in that it affected all types of JAKs investigated here.
The JAK/STAT signaling pathway in response to IFN
stimulates transcription of IFN-inducible genes and
leads to the induction of antiviral actions (Darnell et al.,
1994; Goodbourn et al., 2000; Stark et al., 1998). Many
viruses have evolved several different anti-IFN mecha-
nisms. These mechanisms are divided into two catego-
ries: first is the production of viral proteins that counter-
act the antiviral proteins induced by IFNs, and second is
through the degradation of particular protein compo-
nents that contribute to IFN signaling. In Herpesviridae,
the ICP 34.5 protein of HSV-1 is an example of the first
category. It counteracts PKR-mediated phosphorylation
to prevent the establishment of an antiviral state (He et
al., 1997). For an example of the second category in
Herpesviridae, HCMV reduces basal cellular levels of
Jak1 and p48, thereby preventing the transduction of
JAK/STAT signals (Miller et al., 1998, 1999). Here, we
propose a new third category of anti-IFN mechanisms
that cause dysfunction in the IFN signaling pathway by
the suppression of JAK phosphorylation. Infection with
Sendai virus (SeV), and RNA virus, also results in a slight
reduction of JAK phosphorylation (Komatsu et al., 2000).
owever, it is still unknown whether the inhibitory mech-
nism of SeV is similar to that of HSV-1 as presented in
his study. At a late stage of HSV-1 infection, we have
bserved that basal levels of Jak1 and STAT2 proteins
ecrease in FL cells (Fig. 2). This observation at a late
nfection stage may be a phenomenon similar to that
eported for HCMV (Miller et al., 1998, 1999), falling into
he second category described above. Therefore, we
ropose that the JAK/STAT signal transduction pathway
s strongly impaired by multiple mechanisms during
SV-1 infection, with downregulation of JAK phosphory-
ation during the early infection stage and degradation of
articular components of the signaling pathway late in
he infection process.
Based on our observations that UV-inactivated virus
annot suppress the phosphorylation of STATs in FL cells
Fig. 4), and that the suppression of the JAK/STAT path-
ay does not occur in U937 cells (Fig. 5), which show
esistance to HSV-1 replication, we have concluded that
mpaired or reduced phosphorylation of JAKs seemed to
equire HSV-1 gene expression or production of an
SV-1 protein(s). A newly synthesized viral protein(s)
hould therefore contribute to this event. Recent reports
howed that HSV-1 activates IFN-inducible genes in the
bsence of de novo cellular protein synthesis (Mossman
t al., 2001; Nicholl et al., 2000). This response is seen
nly when viral gene expression is inhibited. So a newly
ynthesized viral protein(s) may function as an inhibitor
f the IFN-inducible gene expression. The observation
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123SUPPRESSION OF IFN SIGNALING BY HSV-1agreed well with our results presented here. Further-
more, Mossman et al. (2000) also showed that an IE
gene product, ICP0 protein, should contribute to the
relative resistance of HSV-1 to IFN, because HSV-1 mu-
tants lacking the ICP0 gene are hypersensitive to IFN.
The human monocytic cell line U937 is an interesting
system, because the primary block in HSV-1 replication
in U937 cells occurs after transport of the viral DNA to
the cell nucleus but prior to steady-state accumulation of
viral RNA for IE genes (Stewart et al., 1992; Tenney and
orahan, 1987, 1991). Stewart et al. (1992) also indicated
hat the resistance to HSV-1 replication in U937 cells is
elated to transcriptional events with regard to the ICP0.
he dysfunction in ICP0 activity in U937 cells may be
nvolved in the lack of IFN-induced Tyr phosphorylation
f STAT1a. The inhibition should result in the suppres-
sion of the initiation step of the HSV-1 replication pro-
cess in early stages of infection. We believe that the
inhibitory mechanism for decreasing IFN signaling that
we present in this study contributes to allowing HSV-1 to
elude this first barrier of the host defense and therefore
to be able to proceed with its replication even in the
presence of IFN. We are currently examining what viral
molecules might participate in the inhibition of JAK and
STAT phosphorylation and how they work.
MATERIALS AND METHODS
Cell culture, virus infections, and IFN treatment
Human amnion cell FL, human monocytic cell U937,
and Vero cells were routinely cultured in RPMI 1640
medium containing 10% (v/v) heat-inactivated fetal bo-
vine serum. HSV-1 strain VR3 was obtained from the
American Type Culture Collection (Rockville, MD). UV-
inactivated virus was prepared by irradiation with a 15-W
UV lamp (GL-15; Toshiba, Tokyo, Japan) at a distance of
10 cm for 5 min. The inactivation was confirmed by a
plaque formation assay using Vero cells and FL cells as
indicator cells.
All HSV-1 infections were done at m.o.i. 5. IFN-a and
IFN-g were purchased from Serotec (Oxford, UK) and
enzyme (Cambridge, MA), respectively. Both were used
t a final concentration of 1000 IU/ml.
ntibodies
Rabbit polyclonal antibodies against STAT1 p84/p91
E-23), STAT2 (C-20), and Jak2 (M-126) were purchased
rom Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit
ntibodies against Jak1 and Tyk2 were from Upstate
iotechnology (Lake Placid, NY). Anti-Tyr701-phosphory-
lated STAT1 antibody was from BioSource International
(Camarillo, CA). Mouse anti-p48 monoclonal antibody
(clone 6) and alkaline phosphatase-conjugated recombi-
nant anti-phosphotyrosine antibody (RC20) were from
Transduction Laboratories (San Diego, CA). Mousemonoclonal antibody to actin (C4) was from Chemicon
(Temecula, CA).
Western blotting
Cells were lysed with 1% Nonidet P-40, 120 mM NaCl,
1 mM dithiothreitol, 10% glycerol, 5 mM EDTA, 1 mM
phenylmethylsulfonyl fluoride, 1 mM Na3VO4, 1 mM NaF,
nd 20 mM HEPES–NaOH, pH 7.5, and the lysates were
entrifuged at 10,000 g for 10 min at 4°C. The superna-
ants were recovered, and the protein concentration was
etermined by the method of Bradford (1976) using bo-
ine serum albumin as a standard. Sodium dodecyl sul-
ate–polyacrylamide gel electrophoresis (SDS-PAGE)
nd Western blotting were carried out as described pre-
iously (Yokosawa et al., 1998; Yokota et al., 1999).
Immunoprecipitation analysis
Cellular proteins were solubilized by RIPA buffer (1%
Nonidet P-40, 0.1% sodium deoxycholate, 100 mM NaCl,
4 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 0.2
mTIU/ml aprotinin, 1 mM Na3VO4, 1 mM NaF, and 50 mM
EPES–NaOH, pH 7.5). The cell lysate and 5 mg antibody
were mixed and incubated at 4°C for 1 h. Protein
G–Sepharose 4B (Amersham Pharmacia, Uppsala, Swe-
den) was added to the mixture and incubated at 4°C
overnight on a rotator. The resin was washed with the
RIPA buffer four times and then the bound materials were
solubilized by boiling with SDS–PAGE sample buffer and
applied to SDS–PAGE on a 6% (w/v) polyacrylamide gel,
followed by Western blotting analysis as above.
Reporter gene assay using luciferases
Expression of IFN-inducible genes was determined by
a dual luciferase reporter assay by transiently transfect-
ing reporter plasmids containing either the ISRE or the
GAS enhancer element. The reporter plasmids, pISRE-
Luc and pGAS-Luc (PathDetect in Vivo Signal Transduc-
tion Pathway cis-Reporting Systems), were purchased
from Stratagene (La Jolla, CA). pISRE-Luc and pGAS-Luc
harbor the enhancer elements (TAGTTTCACTTTCCC)5
and (AGTTTCATATTACTCTAAATC)4, respectively, up-
tream of the firefly luciferase gene. FL cells were plated
nto a 24-well plate at approximately 30% confluency the
ay before transfection. Reporter plasmids (1 mg) and
reference plasmids (0.1 mg of pRL-TK vector, harboring
the HSV thymidine kinase promoter just upstream of
Renilla luciferase; Promega, Madison, WI) were mixed
and transfected into the FL cells using Superfect trans-
fection reagent (Qiagen, Hilden, Germany) according to
the manufacturer’s instruction manual. After cultivation
for 36 h, the transfectants were infected with HSV-1
strain VR3 at m.o.i. 5 or not infected. After 2 h incubation,
IFN-a (for pISRE-Luc transfectants) or IFN-g (for pGAS-
Luc transfectants) was added at a final concentration of
1000 IU/ml and further incubated for 4 h. The cells were
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124 YOKOTA ET AL.lysed, and the firefly luciferase and Renilla luciferase
ctivities in the lysate were measured using the Dual-
uciferase Reporter Assay System (Promega). The ex-
eriments were performed in triplicate. Reporter activity
as calculated as the ratio of firefly luciferase activity to
enilla luciferase activity. The results are expressed as
old induction, which is the value relative to the value of
ontrol experiments with neither HSV-1 infection nor IFN
reatment.
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